首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Nonpeptide endothelin receptor antagonists. IX. Characterization of endothelin receptors in guinea pig bronchus with SB 209670 and other endothelin receptor antagonists.
【24h】

Nonpeptide endothelin receptor antagonists. IX. Characterization of endothelin receptors in guinea pig bronchus with SB 209670 and other endothelin receptor antagonists.

机译:非肽内皮素受体拮抗剂。九。用SB 209670和其他内皮素受体拮抗剂表征豚鼠支气管内皮素受体。

获取原文
获取原文并翻译 | 示例
       

摘要

In this study the endothelin (ET) receptors mediating contractions produced by ET-1, ET-3 and the selective ET(B) ligands sarafotoxin 6c (S6c) and BQ-3020 in guinea pig bronchus were investigated using SB 209670, a nonpeptide, mixed ET(A)/ET(B) receptor antagonist, and the peptide ET receptor antagonists BQ-123 (ET(A) receptor-selective), BQ-788 (ET(B) receptor-selective) and RES-701 (ET(B) receptor-selective). SB 209670 (10 microM) antagonized concentrations induced by ET-1 (pK(B) = 6.1). In contrast, BQ-788 (10 microM) and BQ-123 (10 microM), either alone or in combination, were without significant effect on ET-1 concentration-response curves. SB 209670 (10 microM) and BQ-788 (10 microM) antagonized S6c concentration-response curves with pKB values of 6.6 and 5.5, respectively, whereas RES-701 (10 microM) and BQ-123 (10 microM) were without effect. SB 209670 (10 microM) was about a 10-fold less potent antagonist of contractions produced by ET-3 (pK(B) = 5.4) than of those elicited by S6c. BQ-788 (10 microM), RES-701 (10 microM) and BQ-123 (10 microM) were without effect on ET-3 concentration-response curves. BQ-788 (10 microM) had similar potencies for inhibition of contractions induced by S6c (pK(B) = 5.8) and BQ-3020 (pK(B) = 6.25). These data indicate that contractions induced by ET-1, ET-3, S6c and BQ-3020 in guinea pig bronchus appear to be mediated predominantly via stimulation of ET(B) receptors. However, these receptors are not very sensitive to the standard ET(B) receptor antagonists BQ-788 and RES-701, which suggests that responses produced by these ligands in this tissue involve activation not of the classical ET(B) receptor, but rather of an atypical ET receptor population. The results also provide additional evidence that the potencies of ET receptor antagonists depend upon the specific ET agonist.
机译:在这项研究中,使用SB 209670(一种非肽)研究了介导ET-1,ET-3和选择性ET(B)配体sarafotoxin 6c(S6c)和BQ-3020产生的收缩的内皮素(ET)受体,混合的ET(A)/ ET(B)受体拮抗剂和肽ET受体拮抗剂BQ-123(ET(A)受体选择性),BQ-788(ET(B)受体选择性)和RES-701(ET (B)受体选择性)。由ET-1诱导的SB 209670(10 microM)拮抗浓度(pK(B)= 6.1)。相反,单独或组合使用的BQ-788(10 microM)和BQ-123(10 microM)对ET-1浓度-响应曲线没有显着影响。 SB 209670(10 microM)和BQ-788(10 microM)拮抗的S6c浓度-响应曲线的pKB值分别为6.6和5.5,而RES-701(10 microM)和BQ-123(10 microM)没有影响。 SB 209670(10 microM)是由ET-3产生的收缩作用的有效拮抗剂(pK(B)= 5.4)比由S6c引起的收缩作用低约10倍。 BQ-788(10 microM),RES-701(10 microM)和BQ-123(10 microM)对ET-3浓度-响应曲线没有影响。 BQ-788(10 microM)具有类似的抑制S6c(pK(B)= 5.8)和BQ-3020(pK(B)= 6.25)诱导的收缩的效力。这些数据表明由ET-1,ET-3,S6c和BQ-3020诱导的豚鼠支气管收缩似乎主要是通过刺激ET(B)受体介导的。但是,这些受体对标准的ET(B)受体拮抗剂BQ-788和RES-701不太敏感,这表明这些配体在组织中产生的应答并不涉及经典ET(B)受体的活化,而是活化。非典型ET受体的数量。该结果还提供了另外的证据,即ET受体拮抗剂的效力取决于特定的ET激动剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号